APA (7th ed.) Citation

J, W., & N, W. (2026). Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical Management. Current treatment options in oncology, 27(1), . https://doi.org/10.1007/s11864-026-01401-4

Chicago Style (17th ed.) Citation

J, Wu, and Wang N. "Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical Management." Current Treatment Options in Oncology 27, no. 1 (2026). https://doi.org/10.1007/s11864-026-01401-4.

MLA (9th ed.) Citation

J, Wu, and Wang N. "Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical Management." Current Treatment Options in Oncology, vol. 27, no. 1, 2026, https://doi.org/10.1007/s11864-026-01401-4.